Correlation Between Ardelyx and Verrica Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ardelyx and Verrica Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ardelyx and Verrica Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ardelyx and Verrica Pharmaceuticals, you can compare the effects of market volatilities on Ardelyx and Verrica Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ardelyx with a short position of Verrica Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ardelyx and Verrica Pharmaceuticals.

Diversification Opportunities for Ardelyx and Verrica Pharmaceuticals

0.52
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Ardelyx and Verrica is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Ardelyx and Verrica Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verrica Pharmaceuticals and Ardelyx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ardelyx are associated (or correlated) with Verrica Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verrica Pharmaceuticals has no effect on the direction of Ardelyx i.e., Ardelyx and Verrica Pharmaceuticals go up and down completely randomly.

Pair Corralation between Ardelyx and Verrica Pharmaceuticals

Given the investment horizon of 90 days Ardelyx is expected to generate 0.78 times more return on investment than Verrica Pharmaceuticals. However, Ardelyx is 1.28 times less risky than Verrica Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Verrica Pharmaceuticals is currently generating about -0.04 per unit of risk. If you would invest  314.00  in Ardelyx on November 2, 2024 and sell it today you would earn a total of  233.00  from holding Ardelyx or generate 74.2% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Ardelyx  vs.  Verrica Pharmaceuticals

 Performance 
       Timeline  
Ardelyx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ardelyx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, Ardelyx is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Verrica Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Verrica Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Ardelyx and Verrica Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ardelyx and Verrica Pharmaceuticals

The main advantage of trading using opposite Ardelyx and Verrica Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ardelyx position performs unexpectedly, Verrica Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verrica Pharmaceuticals will offset losses from the drop in Verrica Pharmaceuticals' long position.
The idea behind Ardelyx and Verrica Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Insider Screener
Find insiders across different sectors to evaluate their impact on performance